Regis Healthcare (ASX:REG) 3-Year RORE % : -66.28% (As of Dec. 2025)


ASX:REG Regis Healthcare Ltd ASX:REG
84 GF Score
Price A$6.51
GF Value A$10.49
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Regis Healthcare 3-Year RORE %?

Regis Healthcare ASX:REG 84 3-Year RORE % is -66.28 as of Dec. 2025. GuruFocus rates ASX:REG with a GF Score™ of 84/100 and a GF Value™ of A$10.49 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 605 Healthcare Providers & Services companies, Regis Healthcare ranks worse than 85.62% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Regis Healthcare's 3-Year RORE % for the quarter that ended in Dec. 2025 was -66.28%.

The industry rank for Regis Healthcare's 3-Year RORE % or its related term are showing as below:

ASX:REG's 3-Year RORE % is ranked worse than
85.62% of 605 companies
in the Healthcare Providers & Services industry
Industry Median: 0.74 vs ASX:REG: -66.28

Regis Healthcare  (ASX:REG) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Regis Healthcare 3-Year RORE % Related Terms


Regis Healthcare 3-Year RORE % Historical Data

* Premium members only.

The historical data trend for Regis Healthcare's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regis Healthcare 3-Year RORE % Chart

Regis Healthcare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 200.00 53.82 53.82 -10.41 -76.88

Regis Healthcare Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.79 -10.41 -52.27 -76.88 -66.28

ASX:REG vs HCA, THC, DVA: 3-Year RORE % Comparison

For the Medical Care Facilities subindustry, Regis Healthcare's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regis Healthcare 3-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Regis Healthcare's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Regis Healthcare's 3-Year RORE % falls into.


ASX:REG
84GF Score
Regis Healthcare Ltd ASX:REG
3-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regis Healthcare 3-Year RORE % Calculation

Regis Healthcare's 3-Year RORE % for the quarter that ended in Dec. 2025 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 0.124--0.049 )/( 0.125-0.386 )
=0.173/-0.261
=-66.28 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2025 and 3-year before.

Frequently Asked Questions Learn more about 3-Year RORE % →
What does a 3-Year RORE % of -66.28 mean?
Regis Healthcare (ASX:REG) has a 3-Year RORE % of -66.28 as of Dec. 2025. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Regis Healthcare and its competitors. According to the industry distribution chart, Regis Healthcare ranks #518 out of 605 companies in the Healthcare Providers & Services industry, placing it in the top 85.6%.
Is Regis Healthcare's 3-Year RORE % too high?
Regis Healthcare's current 3-Year RORE % is -66.28. Based on the distribution chart, Regis Healthcare ranks #518 out of 605 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Regis Healthcare has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Regis Healthcare's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Regis Healthcare ranks #518 out of 605 companies for 3-Year RORE %. This places Regis Healthcare in the lower half of its industry. The industry median 3-Year RORE % is 0.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.74, based on 605 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Regis Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regis Healthcare's current 3-Year RORE % is -66.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Regis Healthcare (ASX:REG) is currently considered Possible Value Trap. The stock's GF Value™ is A$10.49, compared to a current price of A$6.51 — trading 37.9% below its estimated fair value. The current 3-Year RORE % is -66.28. Regis Healthcare's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Regis Healthcare (ASX:REG), the current 3-Year RORE % is -66.28 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Regis Healthcare (ASX:REG) Overvalued in 2026?

Based on GuruFocus' analysis, Regis Healthcare stock appears to be undervalued. The current stock price of A$6.51 is trading 37.9% below its estimated GF Value™ of A$10.49. GuruFocus considers Regis Healthcare to be Possible Value Trap.

Key valuation signals for ASX:REG:

  • 3-Year RORE %: -66.28
  • GF Value™: A$10.49 vs. price of A$6.51 (37.9% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the ASX:REG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Regis Healthcare Business Description

Other Exchanges 06K1:Germany
Address 293 Camberwell Road, Level 2, Camberwell, Melbourne, VIC, AUS, 3124
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
84GF Score

Get the complete analysis for ASX:REG

3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$6.51
Price
A$10.49
GF Value